Impact of Increasing BMI on the Success of Neuraxial Blocks in Class III Obese Parturients
Evaluating the Impact of Increasing BMI on the Success of Neuraxial Blocks in Class III Obese Parturients: A Retrospective Cohort Study
1 other identifier
observational
1,917
1 country
1
Brief Summary
This study seeks to compare the success rates, feto-maternal outcomes, and complications associated with different neuraxial blocks in Class III obese parturient undergoing cesarean section
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 2, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedFirst Submitted
Initial submission to the registry
January 16, 2026
CompletedFirst Posted
Study publicly available on registry
January 26, 2026
CompletedJanuary 27, 2026
January 1, 2026
11 months
January 16, 2026
January 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Failed neuraxial block
Determine the occurrence of the conversion to general anesthesia
From onset of block until surgery completion
Secondary Outcomes (2)
Maternal adverse events
From onset of blockade until surgery completion
Fetal outcomes
At one and five minutes after birth
Study Arms (1)
Class III obese parturient
Class III obese parturient undergoing cesarean section under neuraxial block
Interventions
Eligibility Criteria
Class III Obese parturients undergoing C-section under neuraxial blocks in the operating rooms of Women's Wellness and Research Center from 1 January 2025 to 1 December 2024.
You may qualify if:
- Age \> or equal to 18 years
- BMI ≥ 45 kg/m²
- Gestational age ≥ 28 weeks
You may not qualify if:
- Age \< 18 years
- BMI \< 45 kg/m²
- History of venous thromboembolism or arterial disease (e.g., DVT, PE, angina, MI, or stroke)
- Severe active lung, cardiovascular, renal, or liver disorders; autoimmune disease; or hemoglobinopathies
- Hereditary or acquired thrombophilia (e.g., Factor V Leiden mutation or antithrombin deficiency)
- In utero fetal demise (IUFD)
- Failed operative vaginal delivery
- Cesarean for the second twin or multiple pregnancies (triplets or higher)
- IVF pregnancy
- Intraoperative bleeding\>1500mL
- Emergency cesarean section (Category I)
- Presence of large uterine fibroid ≥10 cm
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mariah Ariflead
Study Sites (1)
Women's Wellness and Research Center
Doha, Qatar
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ayten Saracoglu
University of Florida, UF Health, Jacksonville, FL 32209, USA
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Resident Physician
Study Record Dates
First Submitted
January 16, 2026
First Posted
January 26, 2026
Study Start
February 2, 2025
Primary Completion
December 31, 2025
Study Completion
January 1, 2026
Last Updated
January 27, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share